Imcyse SA Employee Directory
Biotechnology ResearchWallonia, Belgium2-10 Employees
Imcyse SA is a clinical-stage biotechnology company focused on developing active and specific immunotherapies for severe autoimmune diseases. Its Imotope platform uses modified synthetic peptides to selectively block improper immune activity, with the aim of treating diseases that lack effective alternatives without broadly compromising immune defenses. The company is based in Liège, in the Wallonia region of Belgium, and originated as a spin-off from KU Leuven. Its lead candidate, IMCY-0098, is in phase 2 clinical testing for early-onset type 1 diabetes, illustrating a focus on autoimmune conditions driven by autoreactive immune cells. Imcyse has engaged in partnerships with industry players, including a collaboration with Pfizer to develop treatments for rheumatoid arthritis.